本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Milestone Pharmaceuticals Inc.

1.26
+0.10008.62%
盘后1.280.0200+1.59%19:59 EDT
成交量:196.22万
成交额:229.09万
市值:6,722.60万
市盈率:-1.89
高:1.26
开:1.17
低:1.09
收:1.16
数据加载中...
2022/11/10

重要事件披露

8-K - Current report
2022/10/31

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/24

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/17

重要事件披露

8-K - Current report
2022/09/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/10

重要事件披露

8-K - Current report
2022/07/08

重要事件披露

8-K - Current report
2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/24

重要事件披露

8-K - Current report
2022/03/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/16

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/31

SEC问询函

CORRESP [Cover] - Correspondence